Skip to main content

Regeneron's COVID-19 drug effective in early disease stage

Company says it is discussing the positive preliminary drug trial results with regulators.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.